Weekly Digest – January 2026 Weekly Digest – January 2026 28 December 2025: Senhwa Biosciences aims at a multi-billion dollar global market with CX-5461 combined with ADC “blockbuster” therapy Senhwa Biosciences announced a Phase 1 clinical trial evaluating its first-in-class […]
Weekly Digest – January 2026 Weekly Digest – January 2026 29 December 2025: Harbour BioMed enters into long-term strategic collaboration with Lannacheng to advance next-generation radionuclide drug conjugates Harbour BioMed entered a long-term strategic collaboration with Yantai Lannacheng Biotechnology to […]
Weekly Digest – January 2026 Weekly Digest – January 2026 31 December 2025: BioAtla and GATC health announce a $40 million special purpose vehicle (SPV) transaction to advance Ozuriftamab Vedotin (Oz-V) into a registrational trial for 2L+ oropharyngeal squamous cell […]
